Skip to main content
Premium Trial:

Request an Annual Quote

Linkage Biosciences Inks European Distribution Deal With Voden

NEW YORK (GenomeWeb) – Linkage Biosciences today announced a distribution partnership with Voden Medical Instruments.

The deal gives Voden rights to distribute Linkage's genetic testing, including the real-time PCR-based LinkSeq human leukocyte antigen (HLA) test.

"Voden Medical possesses a long standing record of excellent customer service and proven technical expertise, particularly in the area of HLA testing," Linkage Biosciences CEO Zachary Antovich said in a statement.  

Earlier this month, South San Francisco, Calif.-based Linkage Biosciences launched a European subsidiary based in Geneva.